Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review. (August 2013)
- Record Type:
- Journal Article
- Title:
- Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review. (August 2013)
- Main Title:
- Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: A critical review
- Authors:
- Pompili, Maurizio
Serafini, Gianluca
Innamorati, Marco
Venturini, Paola
Fusar-Poli, Paolo
Sher, Leo
Amore, Mario
Girardi, Paolo - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Objectives.</italic> The treatment of major affective disorders, commonly associated with high disability and elevated social costs may be still considered unsatisfactory. Among all antidepressant drugs, predominantly acting through monoaminergic mechanisms, agomelatine is of particular interest due to another alternative mechanism of action. Targeting melatonergic receptors, agomelatine play a crucial role in synchronizing circadian rhythms, known to be altered in depressed subjects. <italic>Methods.</italic> A critical review of the literature focusing on efficacy, safety and tolerability of agomelatine in major affective disorders was performed. Additionally, we focused on the potential of agomelatine in enhancing neuroplasticity mechanisms and promote neurogenesis. A total of 136 articles from peer-reviewed journals were identified, of which 50 were assessed for eligibility and 21 were included. <italic>Results.</italic> Agomelatine, a melatonergic analogue drug acting as MT<sub>1</sub>/MT<sub>2</sub> agonist and 5-HT<sub>2C</sub> antagonist, has been reported to be effective as antidepressant drug. Studies confirmed not only clinical efficacy but also safety and tolerability of agomelatine. Also, it enhances neuroplasticity mechanisms and adult neurogenesis in brain areas such as hippocampus and prefrontal cortex. <italic>Conclusions.</italic> Agomelatine actually represents an intriguing option in the treatment of<abstract> <title>Abstract</title> <p> <italic>Objectives.</italic> The treatment of major affective disorders, commonly associated with high disability and elevated social costs may be still considered unsatisfactory. Among all antidepressant drugs, predominantly acting through monoaminergic mechanisms, agomelatine is of particular interest due to another alternative mechanism of action. Targeting melatonergic receptors, agomelatine play a crucial role in synchronizing circadian rhythms, known to be altered in depressed subjects. <italic>Methods.</italic> A critical review of the literature focusing on efficacy, safety and tolerability of agomelatine in major affective disorders was performed. Additionally, we focused on the potential of agomelatine in enhancing neuroplasticity mechanisms and promote neurogenesis. A total of 136 articles from peer-reviewed journals were identified, of which 50 were assessed for eligibility and 21 were included. <italic>Results.</italic> Agomelatine, a melatonergic analogue drug acting as MT<sub>1</sub>/MT<sub>2</sub> agonist and 5-HT<sub>2C</sub> antagonist, has been reported to be effective as antidepressant drug. Studies confirmed not only clinical efficacy but also safety and tolerability of agomelatine. Also, it enhances neuroplasticity mechanisms and adult neurogenesis in brain areas such as hippocampus and prefrontal cortex. <italic>Conclusions.</italic> Agomelatine actually represents an intriguing option in the treatment of affective disorders.</p> </abstract> … (more)
- Is Part Of:
- World journal of biological psychiatry. Volume 14:Number 6(2013)
- Journal:
- World journal of biological psychiatry
- Issue:
- Volume 14:Number 6(2013)
- Issue Display:
- Volume 14, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 14
- Issue:
- 6
- Issue Sort Value:
- 2013-0014-0006-0000
- Page Start:
- 412
- Page End:
- 431
- Publication Date:
- 2013-08
- Subjects:
- Biological psychiatry -- Periodicals
Biological Psychiatry -- Periodicals
616.89 - Journal URLs:
- http://ejournals.ebsco.com/direct.asp?JournalID=113307 ↗
http://informahealthcare.com/loi/wbp ↗
http://www.metapress.com/link.asp?id=113307 ↗
http://informahealthcare.com ↗
http://www.wfsbp.org/publications.html ↗ - DOI:
- 10.3109/15622975.2013.765593 ↗
- Languages:
- English
- ISSNs:
- 1562-2975
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9356.073250
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3055.xml